SCHEMBL11736103

SCHEMBL11736103

O=c1c(Cl)c(NNCC(F)(F)F)cnn1-c1cccc(C(F)(F)F)c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPBWR1 P48145 1/20 0.48
▸ MCHR1 Q99705 1/20 0.48
▸ SMN1; SMN2 Q16637 3/20 0.48
▸ KMT2A Q03164 2/20 0.48
▸ PKM P14618 1/20 0.48
▸ RAB9A P51151 6/20 0.46
▸ NPC1 O15118 4/20 0.46
▸ HPGD P15428 2/20 0.45
▸ MAPT P10636 2/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ GAA P10253 1/20 0.45
▸ CYP1A2 P05177 2/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ HTT P42858 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.43
▸ RXFP1 Q9HBX9 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.42
▸ PAX8 Q06710 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Norflurazone SCHEMBL54676 0.83 CYP1A2 (0.66) NPBWR1MCHR1SMN1; SMN2KMT2APKM
SCHEMBL11727557 0.83 NPBWR1 (0.53) NPBWR1MCHR1SMN1; SMN2KMT2APKM
Norflurazone SCHEMBL29776940 0.83 CYP1A2 (0.66) NPBWR1MCHR1SMN1; SMN2KMT2APKM
Norflurazone SCHEMBL6512279 0.83 CYP1A2 (0.66) NPBWR1MCHR1SMN1; SMN2KMT2APKM
Norflurazone SCHEMBL28530944 0.82 CYP1A2 (0.64) NPBWR1MCHR1SMN1; SMN2KMT2APKM
Norflurazone SCHEMBL7039956 0.82 CYP1A2 (0.64) NPBWR1MCHR1SMN1; SMN2KMT2APKM
SCHEMBL11736112 0.82 NPBWR1 (0.48) NPBWR1MCHR1SMN1; SMN2KMT2APKM
SCHEMBL3037242 0.79 NPC1 (0.64) NPBWR1MCHR1SMN1; SMN2KMT2ARAB9A
Norflurazone SCHEMBL28173162 0.77 CYP1A2 (0.61) NPBWR1MCHR1SMN1; SMN2KMT2APKM
Norflurazone SCHEMBL27382340 0.77 CYP1A2 (0.61) NPBWR1MCHR1SMN1; SMN2KMT2APKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4002751-A SLEEP INDUCERS, CNS DEPRESSANTS SANDOZ, INC. (US) 1977-01-11 — — US disclosed
Send feedback